160 related articles for article (PubMed ID: 7734291)
1. p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies.
Gallo O; Bianchi S; Giovannucci-Uzzielli ML; Santoro R; Lenzi S; Salimbeni C; Abbruzzese M; Alajmo E
Br J Cancer; 1995 May; 71(5):1008-12. PubMed ID: 7734291
[TBL] [Abstract][Full Text] [Related]
2. p53 expression: a potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract.
Gallo O; Bianchi S
Eur J Cancer B Oral Oncol; 1995 Jan; 31B(1):53-7. PubMed ID: 7627089
[TBL] [Abstract][Full Text] [Related]
3. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
4. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
5. Does the bleomycin sensitivity assay express cancer phenotype?
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2003 Jan; 18(1):59-63. PubMed ID: 12473736
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for multiple malignancies in the head and neck.
Deganello A; Gitti G; Mannelli G; Meccariello G; Gallo O
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):105-11. PubMed ID: 23535708
[TBL] [Abstract][Full Text] [Related]
7. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients.
Schantz SP; Hsu TC
Head Neck; 1989; 11(4):337-42. PubMed ID: 2473966
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
9. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.
Field JK; Spandidos DA; Malliri A; Gosney JR; Yiagnisis M; Stell PM
Br J Cancer; 1991 Sep; 64(3):573-7. PubMed ID: 1911200
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
[TBL] [Abstract][Full Text] [Related]
11. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract.
Spitz MR; Hoque A; Trizna Z; Schantz SP; Amos CI; King TM; Bondy ML; Hong WK; Hsu TC
J Natl Cancer Inst; 1994 Nov; 86(22):1681-4. PubMed ID: 7966395
[TBL] [Abstract][Full Text] [Related]
12. [Mutagen sensitivity in patients with multiple primary tumors (MPT) of the head and neck region--quantitative and qualitative assessment based on bleomycin assay].
Wierzbicka M; Jarmuz M; Gajecka M; Kujawski M; Szyfter W; Szyfter K
Otolaryngol Pol; 2004; 58(3):441-9. PubMed ID: 15311585
[TBL] [Abstract][Full Text] [Related]
13. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
14. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies.
Schantz SP; Spitz MR; Hsu TC
J Natl Cancer Inst; 1990 Nov; 82(22):1773-5. PubMed ID: 1700135
[TBL] [Abstract][Full Text] [Related]
15. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract.
Waridel F; Estreicher A; Bron L; Flaman JM; Fontolliet C; Monnier P; Frebourg T; Iggo R
Oncogene; 1997 Jan; 14(2):163-9. PubMed ID: 9010218
[TBL] [Abstract][Full Text] [Related]
16. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol.
Field JK; Zoumpourlis V; Spandidos DA; Jones AS
Cancer Detect Prev; 1994; 18(3):197-208. PubMed ID: 8076382
[TBL] [Abstract][Full Text] [Related]
17. Clinical implication of screening p53 gene mutations in head and neck squamous cell carcinomas.
Ma L; Ronai A; Riede UN; Köhler G
J Cancer Res Clin Oncol; 1998; 124(7):389-96. PubMed ID: 9719502
[TBL] [Abstract][Full Text] [Related]
18. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck.
Pandita TK; Hittelman WN
Int J Cancer; 1995 May; 61(5):738-43. PubMed ID: 7539412
[TBL] [Abstract][Full Text] [Related]
20. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
Mineta H; Borg A; Dictor M; Wahlberg P; Akervall J; Wennerberg J
Br J Cancer; 1998 Oct; 78(8):1084-90. PubMed ID: 9792155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
